PWM
TXG icon

Perigon Wealth Management’s 10x Genomics TXG Stock Holding History

Perigon Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,537
Closed -$373K – 1101
2024
Q3 		$373K Buy
16,537
+3,784
+30% +$78.2K 0.01% 706
2024
Q2 		$248K Sell
12,753
-1,415
-10% -$37.1K 0.01% 756
2024
Q1 		$532K Buy
14,168
+4,512
+47% +$198K 0.02% 516
2023
Q4 		$540K Buy
9,656
+1,818
+23% +$79.1K 0.02% 476
2023
Q3 		$323K Sell
7,838
-2,593
-25% -$135K 0.01% 559
2023
Q2 		$582K Buy
10,431
+81
+0.8% +$4.38K 0.02% 421
2023
Q1 		$577K Buy
10,350
+140
+1% +$6.54K 0.03% 369
2022
Q4 		$372K Buy
10,210
+3,044
+42% +$99.5K 0.02% 464
2022
Q3 		$204K Buy
7,166
+408
+6% +$15.5K 0.02% 543
2022
Q2 		$306K Buy
6,758
+1,541
+30% +$80K 0.03% 426
2022
Q1 		$397K Buy
5,217
+1,331
+34% +$116K 0.03% 407
2021
Q4 		$579K Buy
3,886
+1,600
+70% +$245K 0.04% 310
2021
Q3 		$333K Buy
2,286
+109
+5% +$18.7K 0.03% 392
2021
Q2 		$426K Buy
2,177
+28
+1% +$5.07K 0.04% 340
2021
Q1 		$389K Buy
2,149
+670
+45% +$116K 0.04% 341
2020
Q4 		$209K Buy
+1,479
New +$215K 0.02% 385

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perigon Wealth Management's TXG Position: Q4 2024 in Review

Perigon Wealth Management sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 16,537 shares — an estimated $373K sold.

Perigon Wealth Management first reported a position in TXG in Q4 2020 and held it in 16 quarters. The position peaked at $582K in Q2 2023. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • Perigon Wealth Management reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • Perigon Wealth Management sold 16,537 10x Genomics shares in Q4 2024, an estimated $373K.
  • Perigon Wealth Management first reported a position in 10x Genomics in Q4 2020 and held it in 16 quarters.
  • Perigon Wealth Management's 10x Genomics position peaked at $582K in Q2 2023.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on Perigon Wealth Management's 13F filing for Q4 2024, filed 22 Jan 2025.